Cardlytics Q3 2023 Earnings Report
Key Takeaways
Cardlytics reported a 9% year-over-year increase in revenue, reaching $79.0 million for the third quarter of 2023. The company also saw a significant improvement in gross profit, which increased by 38% compared to the same period last year. Additionally, Cardlytics reported a net loss attributable to common stockholders of $(24.0) million, or $(0.63) per diluted share, and a non-GAAP net loss was $0.3 million, or $0.01 per diluted share.
Revenue increased by 9% year-over-year to $79.0 million.
Gross profit increased by 38% year-over-year to $35.8 million.
Cardlytics MAUs increased by 4% year-over-year to 162.5 million.
Cardlytics ARPU increased to $0.49 compared to $0.47 in the third quarter of 2022.
Cardlytics
Cardlytics
Forward Guidance
Cardlytics anticipates billings to be between $122.0 - $133.0 million, revenue between $82.0 - $90.0 million, adjusted contribution between $44.0 - $50.0 million and adjusted EBITDA between $4.0 - $8.0 million for Q4 2023.